Upcoming events

BIO-Europe Spring

In person

From March 18 to 20, ZoBio will participate in BIO- Europe Spring in Barcelona. With over 3,700 biotechnology and pharma leaders in attendance, it’s a prime venue to establish new partnerships and explore potential business opportunities. 

Jan Schultz, Managing Director of Business Development, will actively participate in One-on-One meetings. These meetings provide a valuable opportunity for direct engagement with potential partners, allowing ZoBio to tailor its pitch and discussions to each individual’s interests and needs.

BIO-Europe Spring presents an excellent platform for ZoBio to network, exchange ideas, and potentially forge valuable partnerships that could drive future growth and innovation.

Drug Discovery Chemistry

In person

Every year ZoBio is actively participating in the Drug Discovery Chemistry event hosted by the Cambridge Healthtech Institute. This event serves as a premier gathering for medicinal chemists in the pharmaceutical and biotech industries, focusing on the challenges and advancements in small molecule drug discovery and optimization.

Johan Veerman’s presentation on Site Directed Hit Discovery to Define the Mode of Action during the Fragment-Based Drug Discovery session will highlight ZoBio’s proficiency in fragment-based drug discovery strategies.

Two days later Gregg Siegal’s lecture Biophysical Approaches to Molecular Glue Discovery will delve into ZoBio’s innovative strategies and methodologies employed in molecular glue discovery, showcasing the company’s expertise and capabilities in this specialized area of drug discovery.

During the entire conference the ZoBio team will be present at the booth # 500 answering all the questions about the company services.

EFMC-ACSMEDI Medicinal Chemistry Frontiers 2024

In person

From 8 to 11 April Johan Veerman and Gregg Siegal will attend ACSMEDI-EFMC Medicinal Chemistry Frontiers symposium. The EFMC | ACSMEDI Medicinal Chemistry Frontiers is co-organized as a collaboration between the EFMC, European Federation for Medicinal Chemistry and Chemical Biology, and ACS MEDI, the division of Medicinal Chemistry of the American Chemical Society. The 2024 edition will be organized in Utrecht, NL, together with the Section for Medicinal Chemistry and Chemical Biology of KNCV.

The meeting attract a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.

On Tuesday, April 9th Johan Veerman will present The Art of Crafting a Mode of Action: Site Selective Hit Discovery. 

Meet us in Utrecht!

Past events

9th RSC-BMCS Fragment-based Drug Discovery Meeting

In person

ZoBio attended the 9th RSC-BMCS Fragment-based Drug Discovery meeting in Cambridge.

The meeting focused on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs. ZoBio was represented by Pim de Vink (Scientist, Assay Development and Screening) who presented poster Screening for Fragment Molecular Glues.

The scientific program was great and a fantastic atmosphere delivered a truly memorable conference!

31th Protein Structure Determination in Industry meeting

In person

Starting from Sunday October 12th the ZoBio team participated in the 31th Protein Structure Determination in Industry meeting, which was held at the Wellcome Genome Campus, Hinxton Cambridge. This year’s meeting was organized jointly by the EMBL-EBI and GSK, supported by Hg3 Conferences. The scientific talks clustered around the following major themes:

  • Synergy of structural and computational approaches
  • Structural biology across modalities
  • Beyond purified protein
  • Integration of data across techniques

Our scientists: Inês Justo and Marc Morgan presented the poster: Tailor-made Structural Biology at ZoBio, highlighting various studies we have performed across our Structural Biology platforms.

During the conference our colleagues had a great opportunity to connect with fellow researchers and learn more about the latest advancements.

Discovery on Target

In person

Our team participated in Discovery on Target, the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. The conference highlighted advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

On Tuesday September 25th ZoBio CEO, Gregg Siegal presented the lecture: ‘The Art of Crafting a Mode of Action: Site Selective Hit Discovery”.

During the entire conference the ZoBio team was present at the booth answering the questions about our capabilities.